 | • レポートコード：MRC2Q12-16860 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ワクシニアキャッピング酵素のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ワクシニアキャッピング酵素のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ワクシニアキャッピング酵素の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ワクシニアキャッピング酵素のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのワクシニアキャッピング酵素の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のワクシニアキャッピング酵素の売上および2028年までの予測に焦点を当てています。 ワクシニアキャッピング酵素のグローバル主要企業には、Thermo Fisher、NEB、Novoprotein、Vazyme、Yeasen Biotechnology (Shanghai)、Hongene Biotech Corporatio、Kactus Biosystemsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ワクシニアキャッピング酵素市場は、タイプとアプリケーションによって区分されます。世界のワクシニアキャッピング酵素市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 5KU、50KU、500KU、5000KU 【アプリケーション別セグメント】 バイオ医薬品企業、学術/研究機関、受託研究機関 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ワクシニアキャッピング酵素製品概要 - タイプ別市場（5KU、50KU、500KU、5000KU） - アプリケーション別市場（バイオ医薬品企業、学術/研究機関、受託研究機関） - 調査の目的 ・エグゼクティブサマリー - 世界のワクシニアキャッピング酵素販売量予測2017-2028 - 世界のワクシニアキャッピング酵素売上予測2017-2028 - ワクシニアキャッピング酵素の地域別販売量 - ワクシニアキャッピング酵素の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ワクシニアキャッピング酵素販売量 - 主要メーカー別ワクシニアキャッピング酵素売上 - 主要メーカー別ワクシニアキャッピング酵素価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（5KU、50KU、500KU、5000KU） - ワクシニアキャッピング酵素のタイプ別販売量 - ワクシニアキャッピング酵素のタイプ別売上 - ワクシニアキャッピング酵素のタイプ別価格 ・アプリケーション別市場規模（バイオ医薬品企業、学術/研究機関、受託研究機関） - ワクシニアキャッピング酵素のアプリケーション別販売量 - ワクシニアキャッピング酵素のアプリケーション別売上 - ワクシニアキャッピング酵素のアプリケーション別価格 ・北米市場 - 北米のワクシニアキャッピング酵素市場規模（タイプ別、アプリケーション別） - 主要国別のワクシニアキャッピング酵素市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのワクシニアキャッピング酵素市場規模（タイプ別、アプリケーション別） - 主要国別のワクシニアキャッピング酵素市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のワクシニアキャッピング酵素市場規模（タイプ別、アプリケーション別） - 主要国別のワクシニアキャッピング酵素市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のワクシニアキャッピング酵素市場規模（タイプ別、アプリケーション別） - 主要国別のワクシニアキャッピング酵素市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのワクシニアキャッピング酵素市場規模（タイプ別、アプリケーション別） - 主要国別のワクシニアキャッピング酵素市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher、NEB、Novoprotein、Vazyme、Yeasen Biotechnology (Shanghai)、Hongene Biotech Corporatio、Kactus Biosystems ・産業チェーン及び販売チャネル分析 - ワクシニアキャッピング酵素の産業チェーン分析 - ワクシニアキャッピング酵素の原材料 - ワクシニアキャッピング酵素の生産プロセス - ワクシニアキャッピング酵素の販売及びマーケティング - ワクシニアキャッピング酵素の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ワクシニアキャッピング酵素の産業動向 - ワクシニアキャッピング酵素のマーケットドライバー - ワクシニアキャッピング酵素の課題 - ワクシニアキャッピング酵素の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Vaccinia Capping Enzyme estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Vaccinia Capping Enzyme is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Vaccinia Capping Enzyme is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Vaccinia Capping Enzyme is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Vaccinia Capping Enzyme include Thermo Fisher, NEB, Novoprotein, Vazyme, Yeasen Biotechnology (Shanghai), Hongene Biotech Corporatio and Kactus Biosystems, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Vaccinia Capping Enzyme companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Vaccinia Capping Enzyme market. Further, it explains the major drivers and regional dynamics of the global Vaccinia Capping Enzyme market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Thermo Fisher
NEB
Novoprotein
Vazyme
Yeasen Biotechnology (Shanghai)
Hongene Biotech Corporatio
Kactus Biosystems
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Vaccinia Capping Enzyme Segment by Type
5KU
50KU
500KU
5000KU
Vaccinia Capping Enzyme Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Vaccinia Capping Enzyme market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Vaccinia Capping Enzyme market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Vaccinia Capping Enzyme, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Vaccinia Capping Enzyme, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccinia Capping Enzyme revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Vaccinia Capping Enzyme market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Vaccinia Capping Enzyme revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher, NEB, Novoprotein, Vazyme, Yeasen Biotechnology (Shanghai), Hongene Biotech Corporatio and Kactus Biosystems, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Vaccinia Capping Enzyme in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccinia Capping Enzyme companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccinia Capping Enzyme revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccinia Capping Enzyme Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 5KU
1.2.3 50KU
1.2.4 500KU
1.2.5 5000KU
1.3 Market by Application
1.3.1 Global Vaccinia Capping Enzyme Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vaccinia Capping Enzyme Market Perspective (2017-2028)
2.2 Vaccinia Capping Enzyme Growth Trends by Region
2.2.1 Vaccinia Capping Enzyme Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Vaccinia Capping Enzyme Historic Market Size by Region (2017-2022)
2.2.3 Vaccinia Capping Enzyme Forecasted Market Size by Region (2023-2028)
2.3 Vaccinia Capping Enzyme Market Dynamics
2.3.1 Vaccinia Capping Enzyme Industry Trends
2.3.2 Vaccinia Capping Enzyme Market Drivers
2.3.3 Vaccinia Capping Enzyme Market Challenges
2.3.4 Vaccinia Capping Enzyme Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccinia Capping Enzyme Players by Revenue
3.1.1 Global Top Vaccinia Capping Enzyme Players by Revenue (2017-2022)
3.1.2 Global Vaccinia Capping Enzyme Revenue Market Share by Players (2017-2022)
3.2 Global Vaccinia Capping Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccinia Capping Enzyme Revenue
3.4 Global Vaccinia Capping Enzyme Market Concentration Ratio
3.4.1 Global Vaccinia Capping Enzyme Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccinia Capping Enzyme Revenue in 2021
3.5 Vaccinia Capping Enzyme Key Players Head office and Area Served
3.6 Key Players Vaccinia Capping Enzyme Product Solution and Service
3.7 Date of Enter into Vaccinia Capping Enzyme Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccinia Capping Enzyme Breakdown Data by Type
4.1 Global Vaccinia Capping Enzyme Historic Market Size by Type (2017-2022)
4.2 Global Vaccinia Capping Enzyme Forecasted Market Size by Type (2023-2028)
5 Vaccinia Capping Enzyme Breakdown Data by Application
5.1 Global Vaccinia Capping Enzyme Historic Market Size by Application (2017-2022)
5.2 Global Vaccinia Capping Enzyme Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Vaccinia Capping Enzyme Market Size (2017-2028)
6.2 North America Vaccinia Capping Enzyme Market Size by Type
6.2.1 North America Vaccinia Capping Enzyme Market Size by Type (2017-2022)
6.2.2 North America Vaccinia Capping Enzyme Market Size by Type (2023-2028)
6.2.3 North America Vaccinia Capping Enzyme Market Share by Type (2017-2028)
6.3 North America Vaccinia Capping Enzyme Market Size by Application
6.3.1 North America Vaccinia Capping Enzyme Market Size by Application (2017-2022)
6.3.2 North America Vaccinia Capping Enzyme Market Size by Application (2023-2028)
6.3.3 North America Vaccinia Capping Enzyme Market Share by Application (2017-2028)
6.4 North America Vaccinia Capping Enzyme Market Size by Country
6.4.1 North America Vaccinia Capping Enzyme Market Size by Country (2017-2022)
6.4.2 North America Vaccinia Capping Enzyme Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Vaccinia Capping Enzyme Market Size (2017-2028)
7.2 Europe Vaccinia Capping Enzyme Market Size by Type
7.2.1 Europe Vaccinia Capping Enzyme Market Size by Type (2017-2022)
7.2.2 Europe Vaccinia Capping Enzyme Market Size by Type (2023-2028)
7.2.3 Europe Vaccinia Capping Enzyme Market Share by Type (2017-2028)
7.3 Europe Vaccinia Capping Enzyme Market Size by Application
7.3.1 Europe Vaccinia Capping Enzyme Market Size by Application (2017-2022)
7.3.2 Europe Vaccinia Capping Enzyme Market Size by Application (2023-2028)
7.3.3 Europe Vaccinia Capping Enzyme Market Share by Application (2017-2028)
7.4 Europe Vaccinia Capping Enzyme Market Size by Country
7.4.1 Europe Vaccinia Capping Enzyme Market Size by Country (2017-2022)
7.4.2 Europe Vaccinia Capping Enzyme Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccinia Capping Enzyme Market Size (2017-2028)
8.2 Asia-Pacific Vaccinia Capping Enzyme Market Size by Type
8.2.1 Asia-Pacific Vaccinia Capping Enzyme Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Vaccinia Capping Enzyme Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Vaccinia Capping Enzyme Market Share by Type (2017-2028)
8.3 Asia-Pacific Vaccinia Capping Enzyme Market Size by Application
8.3.1 Asia-Pacific Vaccinia Capping Enzyme Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Vaccinia Capping Enzyme Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Vaccinia Capping Enzyme Market Share by Application (2017-2028)
8.4 Asia-Pacific Vaccinia Capping Enzyme Market Size by Region
8.4.1 Asia-Pacific Vaccinia Capping Enzyme Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Vaccinia Capping Enzyme Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vaccinia Capping Enzyme Market Size (2017-2028)
9.2 Latin America Vaccinia Capping Enzyme Market Size by Type
9.2.1 Latin America Vaccinia Capping Enzyme Market Size by Type (2017-2022)
9.2.2 Latin America Vaccinia Capping Enzyme Market Size by Type (2023-2028)
9.2.3 Latin America Vaccinia Capping Enzyme Market Share by Type (2017-2028)
9.3 Latin America Vaccinia Capping Enzyme Market Size by Application
9.3.1 Latin America Vaccinia Capping Enzyme Market Size by Application (2017-2022)
9.3.2 Latin America Vaccinia Capping Enzyme Market Size by Application (2023-2028)
9.3.3 Latin America Vaccinia Capping Enzyme Market Share by Application (2017-2028)
9.4 Latin America Vaccinia Capping Enzyme Market Size by Country
9.4.1 Latin America Vaccinia Capping Enzyme Market Size by Country (2017-2022)
9.4.2 Latin America Vaccinia Capping Enzyme Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccinia Capping Enzyme Market Size (2017-2028)
10.2 Middle East & Africa Vaccinia Capping Enzyme Market Size by Type
10.2.1 Middle East & Africa Vaccinia Capping Enzyme Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Vaccinia Capping Enzyme Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Vaccinia Capping Enzyme Market Share by Type (2017-2028)
10.3 Middle East & Africa Vaccinia Capping Enzyme Market Size by Application
10.3.1 Middle East & Africa Vaccinia Capping Enzyme Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Vaccinia Capping Enzyme Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Vaccinia Capping Enzyme Market Share by Application (2017-2028)
10.4 Middle East & Africa Vaccinia Capping Enzyme Market Size by Country
10.4.1 Middle East & Africa Vaccinia Capping Enzyme Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Vaccinia Capping Enzyme Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Vaccinia Capping Enzyme Introduction
11.1.4 Thermo Fisher Revenue in Vaccinia Capping Enzyme Business (2017-2022)
11.1.5 Thermo Fisher Recent Developments
11.2 NEB
11.2.1 NEB Company Details
11.2.2 NEB Business Overview
11.2.3 NEB Vaccinia Capping Enzyme Introduction
11.2.4 NEB Revenue in Vaccinia Capping Enzyme Business (2017-2022)
11.2.5 NEB Recent Developments
11.3 Novoprotein
11.3.1 Novoprotein Company Details
11.3.2 Novoprotein Business Overview
11.3.3 Novoprotein Vaccinia Capping Enzyme Introduction
11.3.4 Novoprotein Revenue in Vaccinia Capping Enzyme Business (2017-2022)
11.3.5 Novoprotein Recent Developments
11.4 Vazyme
11.4.1 Vazyme Company Details
11.4.2 Vazyme Business Overview
11.4.3 Vazyme Vaccinia Capping Enzyme Introduction
11.4.4 Vazyme Revenue in Vaccinia Capping Enzyme Business (2017-2022)
11.4.5 Vazyme Recent Developments
11.5 Yeasen Biotechnology (Shanghai)
11.5.1 Yeasen Biotechnology (Shanghai) Company Details
11.5.2 Yeasen Biotechnology (Shanghai) Business Overview
11.5.3 Yeasen Biotechnology (Shanghai) Vaccinia Capping Enzyme Introduction
11.5.4 Yeasen Biotechnology (Shanghai) Revenue in Vaccinia Capping Enzyme Business (2017-2022)
11.5.5 Yeasen Biotechnology (Shanghai) Recent Developments
11.6 Hongene Biotech Corporatio
11.6.1 Hongene Biotech Corporatio Company Details
11.6.2 Hongene Biotech Corporatio Business Overview
11.6.3 Hongene Biotech Corporatio Vaccinia Capping Enzyme Introduction
11.6.4 Hongene Biotech Corporatio Revenue in Vaccinia Capping Enzyme Business (2017-2022)
11.6.5 Hongene Biotech Corporatio Recent Developments
11.7 Kactus Biosystems
11.7.1 Kactus Biosystems Company Details
11.7.2 Kactus Biosystems Business Overview
11.7.3 Kactus Biosystems Vaccinia Capping Enzyme Introduction
11.7.4 Kactus Biosystems Revenue in Vaccinia Capping Enzyme Business (2017-2022)
11.7.5 Kactus Biosystems Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer